BioCentury
ARTICLE | Financial News

Atossa proposes follow-on

February 17, 2017 7:56 PM UTC

On Feb. 13, drug delivery and cancer company Atossa Genetics Inc. (NASDAQ:ATOS) proposed to raise up to $4 million in a follow-on underwritten by Aegis Capital....

BCIQ Company Profiles

Atossa Therapeutics Inc.